Centessa Pharmaceuticals (CNTA) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist

15.910
+0.160+1.02%

Close Feb 26 16:00 ET

17.000
+1.090+6.85%

Pre 04:40 ET

1.81BMarket Cap-10.47P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

TD Cowen Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating
Moomoo NewsFeb 24 08:31 ET · Ratings
TD Cowen Sticks to Its Buy Rating for Centessa Pharmaceuticals (CNTA)
TipRanksFeb 24 08:06 ET · Ratings
Centessa Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)
SECFeb 14 16:49 ET · Announcements
Centessa Pharmaceuticals Insider Sold Shares Worth $588,944, According to a Recent SEC Filing
MT NewswiresFeb 10 17:38 ET
Insiders Who Sold US$5.8m Of Centessa Pharmaceuticals Made The Right Call
Simply Wall StFeb 10 10:22 ET
Express News | Guggenheim Reiterates Buy on Centessa Pharmaceuticalsto Buy
BenzingaFeb 10 09:11 ET

Comments

Stock_Drift

Sep 26, 2024 05:05

$Centessa Pharmaceuticals (CNTA.US)$

Trytosaveabit

Apr 23, 2024 15:37

Update

$Centessa Pharmaceuticals (CNTA.US)$ Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Dow Jones· 15 mins ago
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...

Trytosaveabit

Apr 22, 2024 06:10

Update

$Centessa Pharmaceuticals (CNTA.US)$ The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy